Dataset Information


Ocular Pathology of Oculocerebrorenal Syndrome of Lowe: Novel Mutations and Genotype-Phenotype Analysis.

ABSTRACT: Mutations in the OCRL1 gene result in the oculocerebrorenal syndrome of Lowe, with symptoms including congenital bilateral cataracts, glaucoma, renal failure, and neurological impairments. OCRL1 encodes an inositol polyphosphate 5-phosphatase which preferentially dephosphorylates phosphatidylinositide 4,5 bisphosphate (PI(4,5)P2). We have identified two novel mutations in two unrelated Lowe syndrome patients with congenital glaucoma. Novel deletion mutations are detected at c.739-742delAAAG in Lowe patient 1 and c.1595-1631del in Lowe patient 2. End stage glaucoma in patient 2 resulted in the enucleation of the eye, which on histology demonstrated corneal keloid, fibrous infiltration of the angle, ectropion uvea, retinal gliosis, and retinal ganglion cell loss. We measured OCRL protein levels in patient keratinocytes and found that Lowe 1 patient cells had significantly reduced OCRL protein as compared to the control keratinocytes. Genotype-phenotype correlation of OCRL1 mutations associated with congenital glaucoma revealed clustering of missense and deletion mutations in the 5-phosphatase domain and the RhoGAP-like domain. In conclusion, we report novel OCRL1 mutations in Lowe syndrome patients and the corresponding histopathologic analysis of one patient's ocular pathology.


PROVIDER: S-EPMC5431454 | BioStudies | 2017-01-01

REPOSITORIES: biostudies

Similar Datasets

2017-01-01 | S-EPMC5665444 | BioStudies
1000-01-01 | S-EPMC1716142 | BioStudies
1000-01-01 | S-EPMC1378076 | BioStudies
2020-01-01 | S-EPMC7586875 | BioStudies
1000-01-01 | S-EPMC3392109 | BioStudies
2019-01-01 | S-EPMC6605811 | BioStudies
2012-01-01 | S-EPMC3652247 | BioStudies
2011-01-01 | S-EPMC3102282 | BioStudies
2019-01-01 | S-EPMC6548226 | BioStudies
2005-01-01 | S-EPMC1196371 | BioStudies